E-viri
PDF
Recenzirano
Odprti dostop
-
McNeil, John J; Woods, Robyn L; Nelson, Mark R; Reid, Christopher M; Kirpach, Brenda; Wolfe, Rory; Storey, Elsdon; Shah, Raj C; Lockery, Jessica E; Tonkin, Andrew M; Newman, Anne B; Williamson, Jeff D; Margolis, Karen L; Ernst, Michael E; Abhayaratna, Walter P; Stocks, Nigel; Fitzgerald, Sharyn M; Orchard, Suzanne G; Trevaks, Ruth E; Beilin, Lawrence J; Donnan, Geoffrey A; Gibbs, Peter; Johnston, Colin I; Ryan, Joanne; Radziszewska, Barbara; Grimm, Richard; Murray, Anne M
The New England journal of medicine, 10/2018, Letnik: 379, Številka: 16Journal Article
In a trial comparing 100 mg of aspirin with placebo in nearly 20,000 community-dwelling persons 70 years of age or older in Australia and the United States, aspirin use had no effect on the rate of survival free from dementia or physical disability.
